Skip to main content

Expression of NR1 subunit of NMDA receptor and PSD-93/95 in rat hippocampus affected by NR1/NR2 antisense oligodeoxynucleotide


Abnormal protein expression of N-methyl-D-aspartate (NMDA) receptors essential subunits (NR1, NR2) and of associated post-synaptic density proteins (PSD-95, PSD-93) were observed in schizophrenic patients (post-mortem studies) [1, 2]. NMDA receptors containing NNR2A/B subunit associate in vivo at synapses with PSD-93 and PSD-95 [3]. In the present study, we have silenced the expression of NR1 and/or NR2 proteins in vivo with the goal of assessing the influence of that protein's alteration on the prepulse inhibition of acoustic startle reaction (PPI) and on the expression of related PSD-95/PSD-93 proteins.

Materials and methods

We used antisense oligodeoxynucleotide for NMDA-NR1 individually or in combination with NR2A or NR2B (aNR1, aNR2A, aNR2B) in the rat hippocampus and evaluated the PPI. Western blot was employed to assess the expression of affected proteins (NR1, NR2A and NR2B) and associated PSD-95/93 proteins.


Changes in expression of NR1 were found. We observed a significant decrease in the hippocampi of rats affected by the combination aNR2A/aNR2B when compared with controls; yet we did not detect changes in other applications. In addition, we found significant changes in the expression of PSD-95, namely a decreased level of this protein in groups treated with NR2A or NR2B. There were no significant changes in NR2A/B and PSD-93 expression and in PPI.


Despite the fact, that the short term silencing of NR1/NR2 did not change PPI, there were changes in expression of PSD-95, which were connected with the NR2A/B subunit whose protein expression was not changed. This suggests that the association of PSD-95 with NR2A/B may occur in the early phase of biosynthesis.


  1. 1.

    Kristiansen LV, Beneyto M, Haroutunian V, Meador-Woodruff JH: Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulated cortex indicate abnormal regional expression in schizophrenia. Mol Psychiatry. 2006, 11: 737-747. 10.1038/

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Clinton SM, Haroutunian VH, Meador-Woodruff JH: Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia. J Neurochem. 2006, 98: 1114-1125. 10.1111/j.1471-4159.2006.03954.x.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Sans N, Petralia RS, Wang YX, Blahos J, Hell JW, Wenthold RJ: A developmental change in NMDA receptor-associated proteins at hippocampal synapses. J Neurosci. 2000, 20: 1260-1271.

    CAS  PubMed  Google Scholar 

Download references


This work was supported by grants GAČR 309/09/HO72 and MŠMT ČR 1M0517.

Author information



Corresponding author

Correspondence to Monika Vrajová.

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution 2.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Vrajová, M., Bubeniková-Valešová, V. & Klaschka, J. Expression of NR1 subunit of NMDA receptor and PSD-93/95 in rat hippocampus affected by NR1/NR2 antisense oligodeoxynucleotide. Ann Gen Psychiatry 9, S147 (2010).

Download citation


  • Protein Expression
  • Early Phase
  • NMDA Receptor
  • Schizophrenic Patient
  • Prepulse Inhibition